Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Analysis Soluble Endoglin and Matrix Metalloproteinase 14 With Elisa Method in the Diagnosis and Severity of Early/Late-onset Preeclampsia

NCT03932877 is registered in ClinicalTrials.gov with Cengiz Gokcek Women's and Children's Hospital as lead sponsor.

NCT NCT03932877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03932877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Analysis Soluble Endoglin and Matrix Metalloproteinase 14 With Elisa Method in the Diagnosis and Severity of Early/Late-onset Preeclampsia
Lead sponsor
Cengiz Gokcek Women's and Children's Hospital
Phase
Observational
Overall status
Completed
Start date
January 30, 2018
Completion date
December 30, 2018
Enrollment
125 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

preeclampsia